Stock Price
67.43
Daily Change
-1.15 -1.68%
Monthly
-1.76%
Yearly
-29.35%
Q2 Forecast
67.11

Merit Medical Systems reported $27.76M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
3M USD 653M 76M Mar/2026
Abbott USD 1.08B 699M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Anika Therapeutics USD 292K 2.62M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Olympus JPY 14.17B 6.03B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
STAAR Surgical USD -18.31M 27.19M Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -5.32M 6.22M Jun/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Terumo JPY 32.65B 2.4B Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025